SLC38A9 regulates SARS-CoV-2 viral entry
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
- National Institute of Mental Health
This publication has 93 references indexed in Scilit:
- Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19Journal of Medical Virology, 2023
- Persistent SARS‐CoV‐2 infection in patients seemingly recovered from COVID‐19The Journal of Pathology, 2023
- Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialIntensive Care Medicine, 2021
- Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2Biophysical Journal, 2021
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersJAMA Internal Medicine, 2021
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same cladeAntiviral Research, 2020
- Hepatitis B virus is degraded by autophagosome-lysosome fusion mediated by Rab7 and related componentsProtein & Cell, 2018
- mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a NutrientCell, 2017
- Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral TherapyJAMA, 2012